Literature DB >> 2143364

LHRH analogue for treatment of recurrent and refractory mastalgia.

H Hamed1, M Caleffi, M A Chaudary, I S Fentiman.   

Abstract

The LHRH analogue Zoladex was used to treat 21 premenopausal women with severe recurrent or refractory breast pain. Severity and pattern of mastalgia, whether cyclical or non-cyclical, was assessed using self-administered record cards. Symptom relief was achieved in 17 (81%) of the patients. This study showed Zoladex to be an effective short-term treatment for refractory and recurrent mastalgia.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2143364      PMCID： PMC2499253     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  11 in total

Review 1.  Tamoxifen and mastalgia. An emerging indication.

Authors:  I S Fentiman
Journal:  Drugs       Date:  1986-12       Impact factor: 9.546

Review 2.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.

Authors:  H M Fraser; J Sandow
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

4.  Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial.

Authors:  I S Fentiman; M Caleffi; H Hamed; M A Chaudary
Journal:  Br J Surg       Date:  1988-09       Impact factor: 6.939

5.  Prolactin response to thyrotropin-releasing hormone stimulation and dopaminergic inhibition in benign breast disease.

Authors:  S Kumar; R E Mansel; L E Hughes; J S Woodhead; C A Edwards; M F Scanlon; R G Newcombe
Journal:  Cancer       Date:  1984-03-15       Impact factor: 6.860

6.  Double-blind controlled trial of tamoxifen therapy for mastalgia.

Authors:  I S Fentiman; M Caleffi; K Brame; M A Chaudary; J L Hayward
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Clinical experience of drug treatments for mastalgia.

Authors:  J K Pye; R E Mansel; L E Hughes
Journal:  Lancet       Date:  1985-08-17       Impact factor: 79.321

8.  Natural history of breast pain.

Authors:  J R Wisbey; S Kumar; R E Mansel; P E Peece; J K Pye; L E Hughes
Journal:  Lancet       Date:  1983-09-17       Impact factor: 79.321

9.  Inadequate corpus luteal function in women with benign breast diseases.

Authors:  L R Sitruk-ware; N Sterkers; I Mowszowicz; P Mauvais-Jarvis
Journal:  J Clin Endocrinol Metab       Date:  1977-04       Impact factor: 5.958

10.  Importance of mastalgia in operable breast cancer.

Authors:  P E Preece; M Baum; R E Mansel; D J Webster; R W Fortt; I H Gravelle; L E Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-01
View more
  4 in total

1.  Optical properties of the breast during spontaneous and birth control pill-mediated menstrual cycles.

Authors:  Michèle C Stahel; Martin Wolf; Ana Baños; R Hornung
Journal:  Lasers Med Sci       Date:  2009-03-17       Impact factor: 3.161

Review 2.  Drug therapy of mastalgia. What are the options?

Authors:  P A Holland; C A Gateley
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

3.  A Randomized Pilot Study of Inositol in Association with Betaine and Boswellia in the Management of Mastalgia and Benign Breast Lump in Premenopausal Women.

Authors:  Vittorio Pasta; Simona Dinicola; Alessandro Giuliani; Abdel Halim Harrath; Saleh H Alwasel; Francesco Tartaglia; Alessandra Cucina; Mariano Bizzarri
Journal:  Breast Cancer (Auckl)       Date:  2016-04-20

4.  Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic.

Authors:  C A Gateley; M Miers; R E Mansel; L E Hughes
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.